HCV assay
US7166426B2 · kind B2 · utility
6Cited by
11References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2003 |
| Grant date | Jan 23, 2007 |
| Priority date | — |
| Expiry date | Sep 8, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/5767
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
An HCV antigen/antibody/antigen assay is provided. The assay employs an isolated first antigen from a region of the HCV polyprotein, and an HCV multiple epitope fusion antigen that includes an epitope from the same region of the polyprotein as the first antigen. Both the first antigen and the multiple epitope fusion antigen bind antibodies present in an HCV-infected sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.